24 May 2013
Keywords: isentress, works, well, untreated, hiv, patients, drug
Article | 18 August 2008
US drug major Merck & Co's Isentress (raltegravir) in combination with two other HIV drugs reduced viral load to undetectable levels ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2008
© 2013 thepharmaletter.com